MeSH term
Frequency | Condition_Probility | English Abstract | 2 | 0.0 |
Female | 6 | 0.0 |
Humans | 17 | 0.0 |
Animals | 7 | 0.0 |
Base Sequence | 2 | 0.0 |
Comparative Study | 2 | 0.0 |
Mice | 6 | 0.0 |
Molecular Sequence Data | 2 | 0.0 |
Rats | 2 | 0.0 |
Male | 8 | 0.0 |
Research Support, Non-U.S. Gov't | 11 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 6 | 0.0 |
Cell Line | 2 | 0.0 |
Mutation | 2 | 0.0 |
Transfection | 3 | 0.0 |
Tumor Cells, Cultured | 2 | 0.0 |
*Chromosomes, Human, Pair 1 | 2 | 0.0 |
Karyotyping | 3 | 0.0 |
Adolescent | 2 | 0.0 |
*Chromosome Mapping | 4 | 0.0 |
*Chromosomes, Human, Pair 5 | 3 | 1.0 |
Colony-Stimulating Factors/*genetics | 3 | 42.0 |
DNA Probes | 2 | 0.0 |
Multigene Family/*genetics | 2 | 1.0 |
Phenotype | 2 | 0.0 |
Receptors, Colony-Stimulating Factor/*genetics | 2 | 18.0 |
*Trisomy | 2 | 1.0 |
Nucleic Acid Hybridization | 2 | 0.0 |
Receptors, Platelet-Derived Growth Factor | 2 | 6.0 |
Bacterial Infections/*cerebrospinal fluid/drug therapy | 2 | 66.0 |
Child, Preschool | 2 | 0.0 |
Double-Blind Method | 2 | 0.0 |
Infant | 2 | 0.0 |
Interleukin-1/*cerebrospinal fluid | 2 | 25.0 |
Meningitis/*cerebrospinal fluid/drug therapy | 2 | 66.0 |
Prospective Studies | 2 | 0.0 |
